Saudi Arabia Consumer Health Market Discussed in New Euromonitor International Report
06 Dec 2012 • by Natalie Aster
Consumer health saw strong growth for the review period as a whole, with this linked to consumers’ growing confidence in self-medication. Consumers began to take an increasingly proactive approach to their health, with this trend encouraged by a stronger media and government focus on health issues. Consumers also began to feel more confident in approaching pharmacists for advice regarding potentially embarrassing health conditions, thanks to the wider provision of female pharmacists and private consulting rooms at chemists/pharmacies.
According to the report “Consumer Health in Saudi Arabia” by Euromonitor International, Multinationals continued to dominate sales of consumer health at the end of the review period. Many consumers regard these players as offering higher quality products, with players such as GlaxoSmithKline also benefiting from strong marketing support. The leading player however continued to be domestic company Saudi Pharmaceutical Industries & Medical Appliances Co (SPIMACO). This player enjoys a strong appeal thanks to offering a wide range of its own branded generics and also offering global brands produced under license such as Merck’s Claritine.
Consumer Health in Saudi Arabia
Published: November, 2012
Price: US$ 2.400,00
Chemists/pharmacies continued to dominate sales of consumer health at the end of the review period. This is chiefly due to strict government controls over distribution, with many products only permitted for sale via chemists/pharmacies. Distribution continued to widen at the end of the review period, however, with kiosks proving increasingly successful within “other” grocery and non-grocery retailers.
More information can be found in the report “Consumer Health in Saudi Arabia” by Euromonitor International.
To order the report or ask for sample pages contact [email protected]